Nitration of tyrosine in biological conditions represents a pathological event that is associated with several neurodegenerative diseases, such as amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease (AD). Increased levels of nitrated proteins have been reported in AD brain and CSF, demonstrating the potential involvement of reactive nitrogen species (RNS) 2 leads to formation of peroxynitrate ONOO ) , which, following protonation, generates cytotoxic species that oxidize and nitrate proteins (Beckman 1996) . (Formally, the NO 2 added to tyrosine is a nitrite, not nitrate, but the literature has consistently used the latter term, so we shall as well in this paper.) The more common amino acidic targets of oxidation are lysine, histidine, cysteine and methionine (Butterfield and Stadtman 1997), whereas tyrosine is the commonly nitrated amino acid (Souza et al. 2001) . In particular, nitration of tyrosine residues is a formal oxidation (Butterfield and Stadtman 1997), a chemical modification that has been used to investigate the mechanism by which tyrosine residues Received November 11, 2002; revised manuscript received February 19, 2003; accepted February 20, 2003. Address correspondence and reprint requests to Professor D. Allan Butterfield, Department of Chemistry and Center of Membrane Sciences, University of Kentucky, Lexington, KY 40506-0055, USA. E-mail: dabcns@uky.edu
Nitration of tyrosine in biological conditions represents a pathological event that is associated with several neurodegenerative diseases, such as amyotrophic lateral sclerosis (Cookson and Shaw 1999) Parkinson's disease (Good et al. 1998 ) and Alzheimer's disease (AD) (Good et al. 1996; Smith et al. 1997) . Increased levels of nitrated proteins have been reported in AD brain and CSF (Tohgi et al. 1999) , demostrating the potential involvement of reactive nitrogen species (RNS) in neurodegeneration associated with this disease. Reaction of NO with O À:
2 leads to formation of peroxynitrate ONOO ) , which, following protonation, generates cytotoxic species that oxidize and nitrate proteins (Beckman 1996) . (Formally, the NO 2 added to tyrosine is a nitrite, not nitrate, but the literature has consistently used the latter term, so we shall as well in this paper.) The more common amino acidic targets of oxidation are lysine, histidine, cysteine and methionine (Butterfield and Stadtman 1997) , whereas tyrosine is the commonly nitrated amino acid (Souza et al. 2001) . In particular, nitration of tyrosine residues is a formal oxidation (Butterfield and Stadtman 1997) , a chemical modification that has been used to investigate the mechanism by which tyrosine residues exert their function in protein activity (Goldstein et al. 2000) . The chemistry of nitration and the effect of nitration on protein function have been extensively studied (Greenacre and Ischiropoulos 2001) . Numerous mammalian proteins are inactivated by nitration of tyrosines (Gow et al. 1996) , among which are manganese superoxide dismutase (Ischiropoulos et al. 1992 ) and glutamine synthase (Berlett et al. 1996) . In addition important enzymes or structural proteins such as manganese superoxide dismutase, neurofilament L, actin, and tyrosine hydroxylase have been indicated as the targets of tyrosine nitration in pathological condition and animal models of disease (Gow et al. 1996) . All these findings suggest an important role of protein nitration in modulating activity of key enzymes in neurodegenerative disorders, although extensive studies on specific targets of protein nitration in disease are still few (Aulak et al. 2001) .
We have recently applied the methods of proteomics to investigations of proteins in AD brain (Castegna et al. 2002a,b) that led to identification of several specific targets of protein oxidation, by coupling two-dimensional immunodetection of protein carbonyls, an index of protein oxidation (Butterfield and Stadtman 1997) , with mass spectrometry analysis (Castegna et al. 2002a,b) . In the present study, we analyzed the 3-nitrotyrosine content in AD brain specimens compared to normal age-matched controls and identified specific targets of protein nitration in AD brain, providing evidence of involvement of nitrosative stress in AD. The results are discussed in terms of specific protein modification and potential mechanisms involved in the neurodegenerative process in AD brain.
Materials and methods

Brain sampling
Inferior parietal lobule (IPL) tissue specimens used for analyses were taken at autopsy from five AD patients and five control subjects, immediately frozen in liquid nitrogen, and stored at ) 80°C. The Rapid Autopsy Program of the University of Kentucky Alzheimer's Disease Research Center (UK ADRC) provides specimens with extremely short post-mortem intervals. Demographic data for the patients are presented in Table 1 . All AD subjects displayed progressive intellectual decline and met NINCDS-ADRDA Workgroup criteria for the clinical diagnosis of probable AD (McKhann et al. 1984) . All AD subjects met accepted guidelines for the histopathologic diagnosis of AD (National Institute on Aging and the Reagan Institute Working Group 1997). Hematoxylin-eosin and modified Bielschowsky staining and 10-D-5 (an antibody to amyloid b-peptide fibrils), ubiquitin, and a-synuclein immunohistochemistry were used on multiple neocortical, hippocampal, entorhinal, amygdala, brainstem and cerebellum sections for diagnosis. Some AD patients were also diagnosed with dementia with Lewy bodies, but the results of these subjects were no different from AD patients with or without the presence of Lewy bodies. Control subjects underwent annual mental status testing as a part of the UK ADRC normal volunteer longitudinal aging study, and did not have a history of dementia or other neurologic disorders. All control subjects had test scores in the normal range. Neuropathologic evaluation of control brains revealed only age-associated gross and histopathologic alterations.
Brain specimens were minced and suspended in 10 mM HEPES buffer (pH 7.4) containing 137 mM NaCl, 4.6 mM KCl, 1.1 mM KH 2 PO 4 , 0.6 mM MgSO 4 and proteinase inhibitors: leupeptin (0.5 mg/mL), pepstatin (0.7 lg/mL), type IIS soybean trypsin inhibitor (0.5 lg/mL), and phenylmethylsulfonyl fluoride (40 lg/mL). Homogenates were centrifuged at 14 000 g for 10 min to remove debris. Protein concentration in the supernatant was determined by the Pierce BCA method.
Two-dimensional gel electophoresis and western blotting Two-dimensional polyacrylamide gel electophoresis was performed in a Bio-Rad system using 110-mm pH 3-10 immobilized pH gradients (IPG) strips and Criterion 8-16% gels (Bio-Rad, Hercules, CA, USA). Samples were dissolved in 8 M urea and mixed 1 : 4 (v/v) with two-dimensional polyacrylamide gel electophoresis sample buffer [8 M urea, 2 M thiourea, 20 mM dithiothreitol, 0.2% (v/v) Biolytes 3-10, 2% CHAPS, and bromophenol blue]. For the first-dimension, 300 lg of protein were applied to a rehydrated IPG strip, and the isoelectric focusing was carried out at 20°C. Before the second-dimension separation, the gel strips were equilibrated for 10 min in 37.5 mM Tris-HCl (pH 8.8) containing 6 M urea, 2% (w/v) sodium dodecyl sulfate, 20% (v/v) glycerol, and 0.5% dithiothreitol, and then re-equilibrated for 10 min in the same buffer containing 4.5% iodacetamide in place of dithiothreitol. AD and control strips were placed on Criterion gels, unstained molecular standards were applied, and the electrophoresis was started. Isoelectric focusing was performed as follows: 300 V for 1 h, then linear gradient to 8000 V for 5 h and finally 20 000 V/h. Second dimension gels were run at 200 V for 65 min.
SYPRO Ruby staining
The gel slabs were fixed in 10% methanol and 7% acetic acid for 30 min. The fixed solution was removed and 100 mL of SYPRO Ruby gel stain (Bio-Rad) was added to each gel and incubated on gently continuous rocker at room temperature (21°C) for 18 h.
For immunoblotting analysis, the electrophoresis was carried out in the same way as described above, and the gels were transferred to a nitrocellulose membrane. The membranes were incubated with rabbit anti-3-nitrotyrosine (3NT) polyclonal antibody (Chemicon, Temecula, CA, USA) diluted 1 : 100 in 0.3% bovine serum albumin/phosphate-buffered saline with 0.01% sodium azide and 0.2% Tween 20 (PBST) for 1 h at room temperature. After incubation with primary antibodies was complete, membranes were washed for 10 min in PBST three times. Secondary antibody (antirabbit alkaline phosphatase-conjugated IgG; Sigma, St Louis, MO, Nitrated proteins in AD brain 1395 USA), diluted 1 : 30 000 in 0.3% bovine serum albumin/PBST, was then added to blots for 1 h at room temperature. Membranes were washed three times (10 min per wash) with PBST and developed using 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT) solution (SigmaFast tablets; Sigma).
Mass spectrometry
In gel digestion on selected gel portions were performed according to Thongboonkerd et al. (2002) . All mass spectra reported in this study were acquired by the University of Kentucky Mass Spectrometry Facility. A Bruker Autoflex MALDI TOF (matrix assisted laser desorption/ionization-time of flight) mass spectrometer (Bruker Daltonic, Billerica, MA, USA) operated in the reflectron mode was used to generate peptide mass fingerprints. Peptides resulting from in-gel digestion were analyzed on a 384 position, 600 lm AnchorChip TM. Target (Bruker Daltonics, Bremen, Germany) and prepared according to AnchorChip recommendations (AnchorChip Technology, Rev. 2, Bruker Daltonics, Bremen, Germany). Briefly, 1 lL of digestate was mixed with 1 lL of alpha-cyano-4-hydoxycinnamic acid (0.3 mg/mL in ethanol : acetone, 2 : 1 ratio) directly on the target and allowed to dry at room temperature. The sample spot was washed with 1 lL of a 1% TFA solution for approximately 60 s. The TFA droplet was gently blown off the sample spot with compressed air. The resulting diffuse sample spot was recrystallized (refocused) using 1 lL of a solution of ethanol : acetone : 0.1% TFA (6 : 3 : 1 ratio). Reported spectra are a summation of 100 laser shots. External calibration of the mass axis was used for acquisition and internal calibration using either trypsin autolysis ions or matrix clusters was applied post acquisition for accurate mass determination. LC/MS/MS spectra were acquired on a Finnigan LCQ 'Classic' quadrupole ion trap mass spectrometer (Finnigan, Co., San Jose, CA, USA). Separations were performed with an HP 1100 HPLC modified with a custom splitter to deliver 4 lL/min to a custom C18 capillary column (300 lm id · 15 cm, packed in-house with Macrophere 300 5 lm C18 (Alltech Associates, Deerfield, IL, USA). Gradient separations consisted of 2 min isocratic at 95% water : 5% acetonitrile (both phases contain 0.1% formic acid), the organic phase was increased to 20% acetonitrile over 8 min, then increased to 90% acetonitrile over 25 min, held at 90% acetonitrile for 8 min, then increased to 95% in 2 min, and finally returned to initial conditions in 10 min (total acquisition time 45 min with a 10-min recycle time). Tandem mass spectra were acquired in a data dependent manner. Three microscans were averaged to generate the data-dependent full scan spectrum. The most intense ion was subjected to tandem mass spectrometry and three microscans were averaged to produce the MS/MS spectrum. Masses subjected to the MS/MS scan were placed on an exclusion list for 2 min.
Analysis of gel images
The analyses of gels and membranes to compare protein and 3NT immunoreactivity content between control and AD samples were performed with HT Analyzer two-dimensional polyacrylamide gel electophoresis software (Genomic Solutions, Inc., Ann Arbor, MI, USA). Images from Sypro Ruby stained gels, used for proteomic analyses, were obtained using a UV transilluminator (Ex. 470 nm, Em. 618 nm, Molecular Dynamics, Sunnyvale, CA, USA) Coomassie Blue stained gels, used to measure protein content, were scanned with a Scanjet 3300C from Hewlett Packard (Palo Alto, CA, USA).
Analysis of peptide sequences
The MALDI and tandem spectra used for protein identification from tryptic fragments were searched against the NCBI protein databases using the MASCOT search engine (http://www.matrixscience.com). Peptide mass fingerprinting used the assumption that peptides are monoisotopic, oxidized at methionine residues and carbamidomethylated at cysteine residues. Up to one missed trypsin cleavage was allowed, although most matches did not contain any missed cleavages. Mass tolerance of 150 p.p.m. was the window of error allowed for matching the peptide mass values. For MS/MS spectra, the peptides were also assumed to be monoisotopic, oxidized at methionine residues and carbamidomethylated at cysteine residues; however, a 0.8-Da MS/MS mass tolerance was used for searching.
Probability based MOWSE scores were estimated by comparison of search results against estimated random match population and were reported as ) 10*LOG 10 (p), where p is the absolute probability. Scores greater than 71 were considered significant, meaning that for scores higher than 71 the probability of that the match is a random event is lower than 0.05. All protein identifications were in the expected size range based on position in the gel.
Statistical analysis
Statistical comparison of carbonyl levels of proteins, matched with 3NT positive spots on two-dimensional blots from AD and agematched control samples, was performed using analysis of variance (ANOVA), with significant difference set at p < 0.05.
Results
Western blot analysis and subsequent immunochemical detection of 3NT (Fig. 1a) allowed identification of modified brain proteins in AD and control brain. Two-dimensional 3NT blots and Comassie Blue-stained two-dimensional gel images (Fig. 1b) from the same sample were matched, and the 3NT immunoreactivity of individual proteins separated by twodimensional polyacrylamide gel electophoresis were normalized to their content, obtained by measuring the intensity of the staining. This approach revealed that among the numerous proteins present in the two-dimensional gel maps, only a few exhibit anti-3NT immunoreactivity. In addition, we found that the positions of proteins in control and AD two-dimensional maps were identical, a finding confirming our previous studies (Aksenov et al. 2000 (Aksenov et al. , 2001 Castegna et al. 2002a,b) . The specificity of the antibody for nitrotyrosine was verified by staining a blot on which nitrous groups were previously reduced to amino groups: the staining did not reveal any appreciable unspecific binding (data not shown).
Identification of possible targets of increased 3NT was achieved by using mass spectrometry analysis. Protein spots used for MALDI mass spectrometry analysis were excised from two-dimensional gels and subjected to trypsin digestion. Six brain proteins from the region boxed in Figs 1(a) and (b) exhibited increased specific 3NT immunoreactivity in AD IPL samples (Fig. 2) . These proteins were successfully identified by mass spectrometry analysis and shown in Table 2 . A typical mass spectrum corresponding to tryptic digests of one of the identified brain proteins is shown in Fig. 3 . Using MASCOT, the probability based MOWSE score was 122 for c-enolase (p < 0.05), with 15 peptide matches, 151 for b-actin (p < 0.05), with 17 peptide matches, 124 for a-enolase (p < 0.05), with 20 peptide matches, 96 for L-lactate dehydrogenase (p < 0.05), with 20 peptide matches, 111 for triosephosphate isomerase (p < 0.05), with 14 peptide matches, and 92 for human polypeptide h3 (p < 0.05), with 12 peptide matches. Four of the samples were also analyzed by LC/MS/MS. The probability based MOWSE score was 1259 for c-enolase (p < 0.05), with 69% peptide coverage, 775 for b-actin (p < 0.05), with 54% peptide coverage, 994 for L-lactate dehydrogenase (p < 0.05), with 73% peptide coverage, and 1152 for a-enolase (p < 0.05), with 57% peptide coverage.
We report a highly significant increase in 3NT in AD brain for a-enolase (312 ± 87% of control, p < 0.01), triosephosphate isomerase (480 ± 209% of control, p ¼ 0.05), and neuropolypeptide h3 (765 ± 371% of control, p ¼ 0.05). The increase of 3NT immunoreactivity in AD vs. control inferior parietal lobule was not significant for b-actin (144 ± 68% of control, p > 0.05), L-lactate dehydrogenase (162 ± 118% of control, p ¼ 0.16) and c-enolase (153 ± 67% of control, p > 0.05). Table 2 presents the results.
Discussion
A large number of studies report the importance of energy metabolism in contributing to the pathogenesis of AD. The glucose metabolism observed in AD brain is reduced (Messier and Gagnon 2000) , especially in the temporoparietal and frontal areas (Mielke et al. 1996) . Similar abnormalities were detected in platelets and fibroblasts from AD (Sheu et al. 1994 ). In addition, AD patients show increased insulin resistance and glucose intolerance (Vanhanen and Soininen 1998) , and glucose intolerance has been reported in animal models of AD (Mattson et al. 1999) . These data together increase the evidence for metabolic impairment in AD, which is additionally supported by the results presented on glycolytic enzymes in the present study.
Alpha and gamma enolases are the two subunits composing the enzyme enolase, which interconverts 2-phosphoglycerate to phosphoenolpyruvate in glycolysis. The ac and cc isoforms are the predominant dimers in the brain, representing the neuron-specific enolases, whereas other forms are mostly present in the heart and skeletal muscle (Keller et al. 1994) . This enzyme has been studied extensively in AD brain. A proteomics method applied to AD brain showed that the level of the a-subunit is increased compared to control brain (Schonberger et al. 2001) . Recently, our proteomic investigation on targets of protein oxidation, which identified a-enolase as specifically oxidized in AD brain (Castegna et al. 2002b) , provided additional evidence of abnormal activity of this enzyme, which may contribute to the impaired glucose metabolism in AD. Abnormal nitration of tyrosine residues of enolases, together with increased tyrosine nitration in triosephosphate isomerase, reported here, might account for decreased enzyme activity, which, in turn, could lead to decreased glycolysis and hypometabolism. The synapse, under oxidative and nitrosative stress in the AD brain, would require ATP to provide energy for proper functioning of ion-motive ATPase to maintain potential gradients, operate pumps, and maintain membrane lipid bilayer asymmetry, etc. That is, our proteomics findings provide a potentially important link between oxidative stressrelated protein modification and metabolic impairment in AD brain.
Neuropolypeptide h3, also known as phosphatidylethanolamine-binding protein (PEBP), hippocampal cholinergic neurostimulating peptide (HCNP), and Raf-kinase inhibitor protein (RKIP), has been extensively studied because of the variety of its functions in the brain. Originally purified from rat hippocampus, neuropolypeptide h3 up-regulates in vitro the production of choline acetyltransferase in cholinergic neurons following NMDA receptor activation (Ojika et al. 1998) . Cholinergic deficits are prominent in AD brain (Katzman and Saitoh 1991) , and it is conceivable that altered activity of this enzyme would result due to nitrosative modification reported here. Moreover, it has been speculated that HCNP might be involved in the pathophysiology of AD, where the expression of HCNP precursor protein mRNA is decreased (Maki et al. 2002) . Nitration of this peptide reported here, might partly explain the decreased in hippocampal neuronal traffic, due to a lack of HCNP-mediated neurotrophic action on cholinergic neurons. In addition, the biochemical activities of the peptide as PEBP and RKIP still need to be clarified with respect to the HCNP activity. The lipid binding activity might be important in AD since nitration of tyrosine residues of this protein might affect bilayer lipid integrity, known to be altered in AD (Prasad et al. 1998; .
Nitration of tyrosine is a selective event, indicating that proximity to the target and protein structure must be important in protein modification (Souza et al. 2001) . Under normal conditions, the NO concentration is negligible with respect to superoxide dismutase, which effectively scavenges O 2 ).
. The tyrosine local environment is crucial for nitration, because negatively charged amino acids surrounding tyrosine might enhance its susceptibility to nitrating agents (Souza et al. 1999) . Naturally, steric hindrance might play a role, especially for tyrosine residues, which are often embedded in the hydrophobic core of the protein. All these observations together support the data presented here, showing that, among the brain proteins appearing on gel images, only a few are modified by nitration. The positive staining for nitrotyrosine in IPL is consistently present only in six proteins, and among those only three show significant increase in nitrotyrosine in AD compared to control. The lack of statistical significance in the remaining proteins is probably related to the events described above, and also the fact that the brain specimens used for the present analysis were from the IPL, a brain region that shows the common hallmarks of AD, but not to the extent of other regions, i.e. hippocampus. Proteins that did not show a significant increase in 3NT staining in AD IPL might be susceptible to nitrosative stress in other brain regions more affected by neurodegeneration in AD. Future studies will determine if this is the case. However, given their identification as targets of nitrosative stress, the possible consequences of a nitration-dependent protein dysfunction in these proteins will be briefly discussed.
Energy metabolism that uses lactate is an important pathway for neuronal energy production. Under prolonged stimulation, lactate competes with glucose, and, under postischemic/hypoxia conditions lactate appears to be the only oxidizible energy substrate available to support neuronal recovery (Schurr et al. 1997a,b) . Nitrative modification of lactate dehydrogenase might account for decreased enzymatic activity, which in turn might fail to provide additional oxidizible power for energy production. In AD brain, where neurodegeneration together with impaired energy metabolism takes place, lack of energetic support of lactate due to the decreased activity of lactate dehydrogenase additionally weakens the already precarious equilibrium between energy production and utilization.
Modification of cytoskeletal proteins and their effects in the cell have been extensively investigated. In particular, actin has been identified as potential target of nitration, due to its high content in tyrosine and its abundance. The effect of nitrated cytoskeletal proteins in disarranging the cytoskeleton (Milzani et al. 1997) and activating cellular responses that lead to apoptosis (Beckman 1996) is important in AD, where b-actin has been identified as a specific target of protein oxidation (Aksenov et al. 2001 ). Here we report actin as a target of protein nitration, confirming the susceptibility of this enzyme to nitrating species and supporting a potential role of oxidative stress in protein modification.
Recently, several studies on protein repair and turnover following nitration have demonstrated that in certain cases tyrosine nitration makes proteins more prone to proteasomal degradation, i.e. the rate of proteolytic cleavage mediated by the 20S proteasome is higher for nitrated proteins (Berlett et al. 1996; Gow et al. 1996; Grune et al. 1998) . Tyrosine nitration might then exert a signaling role, marking the protein for degradation. Additionally, peroxynitrite-dependent protein modification might modulate signaling events, by altering the phosphorylation/dephosphorylation equilibrium, on which the cell counts for signal transmission (Klotz et al. 2002) . Evidence that free nitrotyrosine is increased in AD brain (Hensley et al. 1998 ) is consistent with the notion that proteasomal degradation of proteins modified on tyrosine takes place; however, the well-established decline in proteasomal activity in AD (Keller et al. 2000) , supported by our identification of ubiquitin carboxy-terminal hydrolase L) 1 as a specific target of protein oxidation in AD brain (Castegna et al. 2002a ), provides clues on the possible accumulation of nitrated proteins.
Others have described widespread nitration of tyrosine in AD brain (Good et al. 1996; Smith et al. 1997) . Although these global studies show tyrosine nitration, the identity of specifically nitrated proteins has awaited proteomics to achieve this goal. The present study identifies targets of protein nitration in AD IPL. Under conditions of oxidative stress, which are known to occur in AD brain Butterfield 2002; , specific proteins are modified by nitrating agents. Their possible resulting decreased activity might contribute to the neurodegeneration that is characteristic of AD.
